Multiomics study in adults with phenylketonuria
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at adults with phenylketonuria (PKU) using advanced testing (called multiomics) to understand how the condition affects the body. If you took part in a previous PKU study (ECOPHEN) and are willing to give a saliva sample for DNA analysis, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have phenylketonuria (PKU).
- Your PKU was found through a routine newborn screening test after birth.
- You took part in an earlier study called ECOPHEN and attended its final visit.
- You are able to give a saliva (spit) sample for DNA analysis.
- You have health insurance and are willing to sign a consent form for the genetic testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) cope with daily life, emotions, and relationships, with input from a relative who lives with them. The goal is to better understand the challenges so care can be improved.
This trial tests an experimental medication taken as a pill to see if it can help people with PKU manage their condition. The study will check if the pill is safe and how it affects blood phenylalanine levels.
This study looks at whether checking phenylalanine levels at home more often helps people with classic PKU keep their levels in a healthy range. It may help you manage your diet and treatment more effectively.
This study looks at how common obesity is in adults with PKU and what factors may contribute to it.
This study tests a new one-time gene therapy injection (called GS1168) for adults with phenylketonuria (PKU). It aims to help your body break down the amino acid phenylalanine better, so your diet may become less strict.
This study tests a new injection called PL54 to see if it is safe and tolerable for adults with phenylketonuria (PKU), a condition where the body cannot break down an amino acid called phenylalanine. It is designed for people with high blood phenylalanine levels and may offer a new treatment option.
Hear when a new Phenylketonuria (PKU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.